Search results for: 'partnering agreements while regener pharmaceutical 2016 2016'
- Related search terms
- partnering agreements with the medicine compani 2014 2020
- partnering agreements with new therapeutics 2017 2017
- partnering agreements while bone 2016 2016
- partnering agreements while regen pharmaceutical 2016 2016
- partnering agreements with new therapeutics 2016 2016
-
Medical Device Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Medical Device Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025March 2025$3,995.00Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Distribution Deals in Pharmaceuticals and Biotechnology 2020 to 2025March 2025$3,995.00Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Autoimmune Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Hematology Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Hematology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025March 2025$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Viral Vector Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cardiovascular Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
